(Q39214769)

10 September 2017

title

MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas (English)

1 reference

10 September 2017

1 reference

1 reference

1 reference

Yu-Quan Wang

1

1 reference

10 September 2017

Ren-De Guo

2

1 reference

10 September 2017

Rui-Meng Guo

3

1 reference

10 September 2017

Wei Sheng

4

1 reference

10 September 2017

Li-Rong Yin

5

1 reference

10 September 2017

publication date

1 July 2013

1 reference

Journal of Cellular Biochemistry

10 September 2017

published in

1 reference

10 September 2017

volume

114

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

1464-1473

1 reference

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

10 September 2017

cites work

1 reference

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

21 January 2018

1 reference

21 January 2018

miRNAs in human cancer

1 reference

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

Optimal chemotherapy treatment for women with recurrent ovarian cancer

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2001

1 reference

MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4).

21 January 2018

1 reference

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions

21 January 2018

1 reference

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation

21 January 2018

1 reference

The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells

21 January 2018

1 reference

Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors

21 January 2018

1 reference

A genetically defined model for human ovarian cancer

21 January 2018

1 reference

MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.

21 January 2018

1 reference

The microcosmos of cancer

21 January 2018

1 reference

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors

21 January 2018

1 reference

Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression

21 January 2018

1 reference

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

21 January 2018

1 reference

The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes.

21 January 2018

1 reference

Modulation of microRNA processing by p53

21 January 2018

1 reference

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

21 January 2018

1 reference

PDCD4 inhibits the malignant phenotype of ovarian cancer cells

21 January 2018

1 reference

Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer

21 January 2018

1 reference

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

21 January 2018

1 reference

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

21 January 2018

1 reference

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion

21 January 2018

1 reference

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24488

1 reference

10 September 2017

1 reference